Recalled batches of products manufactured by PHARMATHEN INTERNATIONAL
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Ryxidal 25 mg RISPERIDONE 2103233397 4400435, 4400888, PHARMATHEN INTERNATIONAL Ryxidal 37.5 mg RISPERIDONE 2103233399 4400436, 4401177, 4401795 Ryxidal 50 mg RISPERIDONE 2103233398 4400437...
التصنيف
ملف
التاريخ
2026-01-07
اسم المستحضر
Ryxidal 25 mg & 37.5 mg &50 mg / Syngro 20 mg & 30 mg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The SFDA has issued a recall for products manufactured by PHARMATHEN INTERNATIONAL due to non-compliance with the approved specifications, following the company’s decision to withdraw the products from the local market.
التوصيات
For healthcare professionals: Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.